This is in accordance with a recent study by Kickingereder et al. that reported a markedly higher relative cerebral blood volume (rCBV) in IDH1/2 wild-type gliomas compared to IDH1/2 mutant gliomas [14]. The gene discussed is IDH1; the disease is central nervous system cancer.